Miki Nonaka

7PUBLICATIONS
12CO-AUTHORS
ChemotherapyTraditional Chinese medicine and treatmentsBiologically active moleculesProteins and peptidesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 30, 2025
The Flavonoids and Monoterpenes from Citrus unshiu Peel Contained in Ninjinyoeito Synergistically Activate Orexin 1 Receptor: A Possible Mechanism of the Orexigenic Effects of Ninjinyoeito.

Kaori Ohshima, Kanako Miyano, Miki Nonaka

|May 11, 2024
The Inhibition of TREK-1 K+ Channels via Multiple Compounds Contained in the Six Kamikihito Components, Potentially Stimulating Oxytocin Neuron Pathways.

Kanako Miyano, Miki Nonaka, Masahiro Sakamoto

|Oct 14, 2023
Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol.

Fumika Karaki, Taro Takamori, Koumei Kawakami

|Jun 28, 2023
Therapeutic Potential of Orally Administered Rubiscolin-6.

Yusuke Karasawa, Kanako Miyano, Masahiro Yamaguchi

|May 13, 2023
Distinct Profiles of Desensitization of µ-Opioid Receptors Caused by Remifentanil or Fentanyl: In Vitro Assay with Cells and Three-Dimensional Structural Analyses.

Eiko Uezono, Yusuke Mizobuchi, Kanako Miyano

|Oct 23, 2021
Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway.

Kanako Miyano, Yuki Yoshida, Shigeto Hirayama

Pageof 2

Frequent Collaborators

3 joint publications

Kanako Miyano

3 joint publications

Keisuke Yamaguchi

3 joint publications

Hideaki Fujii

2 joint publications

Yusuke Karasawa